| Wednesday, August 15th

Patient information seminars in Stockholm (11.9.2018) and in Helsinki (4.10.2018)

EPDA | Thursday, January 18th

Parkinson’s prevalence expected to increase by 18% by 2025

Read More
Herantis Pharma | Wednesday, September 27th

Patient recruitment started and first patient consented in the CDNF Phase I-II clinical study

Read more
TreatER | Friday, June 30th

TreatER Horizon 2020 program website launched

EPDA | Wednesday, May 24th

How wearable devices can help people with Parkinson’s communicate better with their doctors

Read More